谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL

P. L. Zinzani,M. Özcan,K. Sapunarova,W. Jurczak, A. Hamed,K. Bouabdallah,G. Saydam,K. Geissler,Á. Szomor,M. Lazaroiu, A. Salar,A. Tempescul,M. Nalcaci,L. Gercheva,M. Egyed,P. Panayiotidis,L. Mongay Soler,A. Cao, C. Phelps,B. H Childs,M. J Matasar

HemaSphere（2022）

引用 0|浏览11
暂无评分
关键词
Relapse Risk,Treatment Outcomes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要